TRIM40 and inflammatory bowel disease: In summary, our study opens up the exciting possibility that targeting specific mechanisms regulating the transition to chronic inflammation driven by the TRIM40-mediated devastation of intestinal homeostasis could represent a strategy for treating IBD.